- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 417/10
Total number of patents in this class: 1183
10-year publication summary
|
93
|
77
|
93
|
100
|
85
|
80
|
55
|
80
|
59
|
34
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5818 |
57 |
| Merck Sharp & Dohme LLC | 3742 |
33 |
| Bristol-myers Squibb Company | 4884 |
29 |
| LG Chem, Ltd. | 17639 |
29 |
| F. Hoffmann-La Roche AG | 7920 |
24 |
| Genentech, Inc. | 3983 |
21 |
| Novartis AG | 10829 |
19 |
| Syngenta Participations AG | 1900 |
19 |
| Boehringer Ingelheim International GmbH | 4644 |
17 |
| Amgen Inc. | 4049 |
15 |
| Omeros Corporation | 307 |
15 |
| Gilead Sciences, Inc. | 2038 |
14 |
| Bayer AG | 3336 |
13 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
12 |
| Bayer Pharma AG | 1047 |
11 |
| Vertex Pharmaceuticals Incorporated | 1595 |
10 |
| Astex Therapeutics Limited | 236 |
10 |
| Hodogaya Chemical Co., Ltd. | 435 |
10 |
| Glaxosmithkline LLC | 536 |
9 |
| Samsung Display Co., Ltd. | 34842 |
9 |
| Other owners | 807 |